ZENTALIS PHARMACEUTICALS INC. - COMMON STOCK
N/A
31-December-69 19:00:00
15 minutes delayed
Stocks
N/A
Today's range
N/A - N/A
ISIN
N/A
Source
NASDAQ
-
06 Sep 2023 07:00:01 By Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01 Sep 2023 16:37:58 By Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals Reports Second Quarter 2023 Financial Results and Operational Updates
09 Aug 2023 07:00:00 By Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
01 Aug 2023 16:28:31 By Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals Appoints Kimberly Freeman as Chief Strategy Officer
01 Aug 2023 07:00:00 By Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals Announces Pricing of Underwritten Offering of Common Stock
15 Jun 2023 06:01:28 By Nasdaq GlobeNewswire
-
06 Jun 2023 06:00:00 By Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals Reports First Quarter 2023 Financial Results and Operational Updates
10 May 2023 07:00:01 By Nasdaq GlobeNewswire
-
17 Apr 2023 09:00:01 By Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals Reports Full Year 2022 Financial Results and Operational Updates
01 Mar 2023 07:00:01 By Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals Appoints Dr. Iris Roth as Chief Operating Officer
13 Feb 2023 07:00:00 By Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
01 Feb 2023 17:00:41 By Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals to Participate in Two Upcoming Investor Conferences
01 Feb 2023 07:01:00 By Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 Jan 2023 17:00:00 By Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01 Dec 2022 17:00:00 By Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals Reports Third Quarter 2022 Financial Results and Operational Updates
09 Nov 2022 07:00:02 By Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals to Participate in the Stifel 2022 Healthcare Conference
08 Nov 2022 07:01:00 By Nasdaq GlobeNewswire